Study to Learn More About the Effect of a New Drug Called BAY2327949 on the Blood Flow Through Kidneys in Adult Participants With Moderate Chronic Kidney Disease

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2020

Primary Completion Date

December 21, 2020

Study Completion Date

May 5, 2021

Conditions

Moderate Chronic Kidney Disease

Interventions

DRUG

BAY2327949

Single dose of 90 mg BAY2327949

DRUG

Placebo

Single dose of placebo to BAY 2327949

Trial Locations (1)

Steno Diabetes Center Copenhagen, Herlev